Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Short-term Investments (2020 - 2025)

Corbus Pharmaceuticals Holdings has reported Short-term Investments over the past 4 years, most recently at $192000.0 for Q4 2023.

  • For Q4 2023, Short-term Investments changed 0.25% year-over-year to $192000.0; the TTM value through Dec 2023 reached $192000.0, changed 0.25%, while the annual FY2023 figure was $192000.0, 0.25% changed from the prior year.
  • Short-term Investments for Q4 2023 was $192000.0 at Corbus Pharmaceuticals Holdings, down from $17.5 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $72.6 million in Q4 2021 and troughed at $192000.0 in Q4 2023.
  • A 4-year average of $23.5 million and a median of $8.9 million in 2020 define the central range for Short-term Investments.
  • On a YoY basis, Short-term Investments climbed as much as 27844.18% in 2022 and fell as far as 99.74% in 2022.
  • Year by year, Short-term Investments stood at $350000.0 in 2020, then skyrocketed by 20654.43% to $72.6 million in 2021, then crashed by 99.74% to $192475.0 in 2022, then decreased by 0.25% to $192000.0 in 2023.
  • Business Quant data shows Short-term Investments for CRBP at $192000.0 in Q4 2023, $17.5 million in Q3 2023, and $28.2 million in Q2 2023.